Zydus Pharmaceuticals USA Inc recalls BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 5…
- Recall date
- November 2, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0207-2017
- FDA classification
- Class III
- Brand / firm
- Zydus Pharmaceuticals USA Inc
- Sold / distributed
- Nationwide
Why it was recalled
Failed Dissolution Specifications; 6 month time point
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534
Get recall alerts
Free email alert whenever Zydus Pharmaceuticals USA Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Zydus Pharmaceuticals USA Inc